Italia markets open in 1 hour 30 minutes
  • PR Newswire

    GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024

    GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer detection at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4. This research was conducted through a collaborative effort with Genece Health Inc., a strategic partner based in San Diego.

  • Reuters

    Italian shoemaker Tod's to court US lovers of quiet luxury

    An investment firm backed by LVMH is betting demand from wealthy Americans for quiet luxury will ensure its 510 million euro ($545 million) stake in Italian shoemaker Tod's yields the double-digit returns private equity typically seeks. L Catterton, created by U.S. fund Catterton and LVMH-owner Groupe Arnault, on Friday secured sufficient shares to take Tod's private once the deal, valuing the company at just over 1.4 billion euros ($1.5 billion), formally concludes in the coming days. Listed in Milan but controlled by its founding Della Valle family, Tod's profitability has lagged rivals.

  • PR Newswire

    Salmon Evolution ASA: NOK 40/kg in farming EBITDA margin in Q1 2024

    Salmon Evolution ASA ("Salmon Evolution" or the "Company", OSE: SALME) reported operating revenues of NOK 100.3 million in the first quarter of 2024 and a group EBITDA of NOK 24.1 million. The first quarter constitutes a significant milestone for Salmon Evolution with strong profitability and positive EBIT at Group level.